封面
市场调查报告书
商品编码
1742539

医生配发的药妆市场-全球产业分析、规模、份额、成长、趋势和预测(2025-2035)

Physician Dispensed Cosmeceuticals Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2025-2035

出版日期: | 出版商: Transparency Market Research | 英文 251 Pages | 商品交期: 2-10个工作天内

价格

医生配发的药妆品市场-报告范围

TMR 关于全球医师配发药妆市场的报告研究了过去和当前的成长趋势和机会,以获得关于 2025 年至 2035 年预测期内市场指标的宝贵见解。该报告提供了 2019 年至 2035 年期间全球医师配发药妆市场的收入,以 2025 年为基准年,2035 年为预测年。报告中也提供了 2025 年至 2035 年期间全球医师配发药妆市场的年复合成长率(CAGR%)。

本报告经过广泛的调查后编写。主要研究工作包括:分析师对关键意见领袖、产业领导者和舆论领袖进行访谈。次要研究则参考了主要参与者的产品说明书、年度报告、新闻稿和相关文件,以了解医师配发的药妆市场。

市场概况
2024 年的市场价值 207亿美元
2035年的市场价值 446亿美元
复合年增长率 7.1%

本报告深入探讨了全球医师配发药妆市场的竞争格局。该报告确定了全球医师配发药妆市场的主要参与者,并根据不同特点对每家公司进行了分析。本报告对全球医师配发药妆市场的参与者进行了分析,内容涵盖公司概况、财务状况、近期发展和 SWOT 分析。

目录

第一章:前言

第二章:研究方法

第三章:执行摘要:全球市场

第四章:市场概览

  • 介绍
  • 概述
  • 市场动态
  • 2020-2035年全球医师配发药妆市场分析与预测

第五章:关键见解

  • 技术进步
  • 关键产品/品牌分析
  • 关键产业发展
  • 各地区/全球监管状况
  • 波特五力分析
  • PESTEL分析
  • 化妆品和药妆中奈米技术的见解
  • 医生配发的药妆产品的消费者行为模式分析

第六章:全球市场分析与预测:依产品类型

  • 介绍和定义
  • 主要发现/进展
  • 2020 年至 2035 年产品类型市场价值预测
    • 保养产品
      • 抗衰老产品
      • 痤疮治疗产品
      • 皮肤美白和色素沉着
      • 肉毒桿菌毒素
      • 真皮填充剂
      • 其他的
    • 护髮产品
      • 头髮修復
      • 去屑
      • 防脱髮
      • 头皮修復
      • 其他的
    • 眼部护理产品
    • 其他的
  • 按产品类型分類的市场吸引力

第七章:全球市场分析与预测:依管理途径

  • 介绍和定义
  • 主要发现/进展
  • 2020 年至 2035 年按给药途径分類的市场价值预测
    • 口服
    • 外用
    • 肠外
    • 其他的
  • 按给药途径分類的市场吸引力

第八章:全球市场分析与预测:依性别

  • 介绍和定义
  • 主要发现/进展
  • 2020-2035年按性别分類的市场价值预测
    • 男性
    • 女性
  • 不同性别的市场吸引力

第九章:全球市场分析与预测:按配方

  • 介绍和定义
  • 主要发现/进展
  • 2020 年至 2035 年市场价值预测(按配方)
    • 药片
    • 胶囊
    • 洗剂
    • 注射剂
    • 其他的
  • 配方的市场吸引力

第十章:全球市场分析与预测:按配销通路

  • 介绍和定义
  • 主要发现/进展
  • 2020-2035年配销通路市场价值预测
    • 皮肤科诊所
    • 医疗水疗中心
    • 设有皮肤科的医院
    • 健康中心
    • 零售药局
    • 线上平台
  • 配销通路的市场吸引力

第 11 章:全球市场分析与预测:按地区

  • 主要发现
  • 各地区市场价值预测
    • 北美洲
    • 欧洲
    • 亚太地区
    • 拉丁美洲
    • 中东和非洲
  • 各地区市场吸引力

第十二章:北美市场分析与预测

  • 我们
  • 加拿大
  • 德国
  • 英国
  • 法国
  • 义大利
  • 西班牙
  • 欧洲其他地区

第十四章:亚太市场分析与预测

  • 中国
  • 印度
  • 日本
  • 澳洲和纽西兰
  • 亚太其他地区

第十五章:拉丁美洲市场分析与预测

  • 巴西
  • 墨西哥
  • 拉丁美洲其他地区

第十六章:中东与非洲市场分析与预测

  • 海湾合作委员会国家
  • 南非
  • 中东和非洲其他地区

第 17 章:竞争格局

  • 市场参与者 - 竞争矩阵(依公司层级和规模)
  • 各公司市占率分析(2024 年)
  • 公司简介
    • AbbVie Inc. (Allergan)
    • L'Oreal SA (Skinbetter Science)
    • Jan Marini Skin Research, Inc.
    • Athena Cosmetics, Inc.
    • ZO Skin Health Inc.
    • Galderma Laboratories, LP
    • Procter & Gamble Co.
    • The Estée Lauder Companies, Inc.
    • Merz Pharma
    • Obagi Cosmeceuticals LLC
    • iS CLINICAL
    • Velius, LLC
    • Sonoma Pharmaceuticals, Inc.
    • Sientra, Inc.
    • Dynamic Techno Medicals
    • Bausch Health Companies Inc.
Product Code: TMRGL565

Physician Dispensed Cosmeceuticals Market - Scope of Report

TMR's report on the global physician dispensed cosmeceuticals market studies the past as well as the current growth trends and opportunities to gain valuable insights of the indicators of the market during the forecast period from 2025 to 2035. The report provides revenue of the global physician dispensed cosmeceuticals market for the period 2019-2035, considering 2025 as the base year and 2035 as the forecast year. The report also provides the compound annual growth rate (CAGR %) of the global physician dispensed cosmeceuticals market from 2025 to 2035.

The report has been prepared after an extensive research. Primary research involved bulk of the research efforts, wherein analysts carried out interviews with key opinion leaders, industry leaders, and opinion makers. Secondary research involved referring to key players' product literature, annual reports, press releases, and relevant documents to understand the physician dispensed cosmeceuticals market.

Market Snapshot
Market Value in 2024US$ 20.7 Bn
Market Value in 2035US$ 44.6 Bn
CAGR7.1%

Secondary research also included Internet sources, statistical data from government agencies, websites, and trade associations. Analysts employed a combination of top-down and bottom-up approaches to study various attributes of the global physician dispensed cosmeceuticals market.

The report includes an elaborate executive summary, along with a snapshot of the growth behavior of various segments included in the scope of the study. Moreover, the report throws light on the changing competitive dynamics in the global physician dispensed cosmeceuticals market. These serve as valuable tools for existing market players as well as for entities interested in participating in the global physician dispensed cosmeceuticals market.

The report delves into the competitive landscape of the global physician dispensed cosmeceuticals market. Key players operating in the global physician dispensed cosmeceuticals market have been identified and each one of these has been profiled in terms of various attributes. Company overview, financial standings, recent developments, and SWOT are the attributes of players in the global physician dispensed cosmeceuticals market profiled in this report.

Key Questions Answered in global physician dispensed cosmeceuticals Market Report:

  • What is the sales/revenue generated by physician dispensed cosmeceuticals across all regions during the forecast period?
  • What are the opportunities in the global physician dispensed cosmeceuticals market?
  • What are the major drivers, restraints, opportunities, and threats in the market?
  • Which regional market is set to expand at the fastest CAGR during the forecast period?
  • Which segment is expected to generate the highest revenue globally in 2035?
  • Which segment is projected to expand at the highest CAGR during the forecast period?
  • What are the market positions of different companies operating in the global market?

Physician Dispensed Cosmeceuticals Market - Research Objectives and Research Approach

The comprehensive report on the global physician dispensed cosmeceuticals market begins with an overview, followed by the scope and objectives of the study. The report provides detailed explanation of the objectives behind this study and key vendors and distributors operating in the market and regulatory scenario for approval of products.

For reading comprehensibility, the report has been compiled in a chapter-wise layout, with each section divided into smaller ones. The report comprises an exhaustive collection of graphs and tables that are appropriately interspersed. Pictorial representation of actual and projected values of key segments is visually appealing to readers. This also allows comparison of the market shares of key segments in the past and at the end of the forecast period.

The report analyzes the global physician dispensed cosmeceuticals market in terms of product, end-user, and region. Key segments under each criterion have been studied at length, and the market share for each of these at the end of 2035 has been provided. Such valuable insights enable market stakeholders in making informed business decisions for investment in the global physician dispensed cosmeceuticals market.

Table of Contents

1. Preface

  • 1.1. Market Definition and Scope
  • 1.2. Market Segmentation
  • 1.3. Key Research Objectives
  • 1.4. Research Highlights

2. Research Methodology

3. Executive Summary: Global Physician Dispensed Cosmeceuticals Market

4. Market Overview

  • 4.1. Introduction
    • 4.1.1. Segment Definition
  • 4.2. Overview
  • 4.3. Market Dynamics
    • 4.3.1. Drivers
    • 4.3.2. Restraints
    • 4.3.3. Opportunities
  • 4.4. Global Physician Dispensed Cosmeceuticals Market Analysis and Forecasts, 2020-2035
    • 4.4.1. Market Revenue Projections (US$ Bn)

5. Key Insights

  • 5.1. Technological Advancements
  • 5.2. Key Product/Brand Analysis
  • 5.3. Key Industry Developments
  • 5.4. Regulatory Scenario by Region/globally
  • 5.5. Porter's Five Forces Analysis
  • 5.6. PESTEL Analysis
  • 5.7. Insights on Nanotechnology in Cosmetics and Cosmeceuticals
  • 5.8. Consumer Behavior Patterns Analysis for Physician Dispensed Cosmeceuticals Products

6. Global Physician Dispensed Cosmeceuticals Market Analysis and Forecasts, By Product Type

  • 6.1. Introduction & Definition
  • 6.2. Key Findings / Developments
  • 6.3. Market Value Forecast By Product Type, 2020-2035
    • 6.3.1. Skincare Products
      • 6.3.1.1. Anti-aging Products
      • 6.3.1.2. Acne treatment Products
      • 6.3.1.3. Skin Whitening and Hyperpigmentation
      • 6.3.1.4. Botulinum Toxin
      • 6.3.1.5. Dermal fillers
      • 6.3.1.6. Others
    • 6.3.2. Hair Care Products
      • 6.3.2.1. Hair Repair
      • 6.3.2.2. Anti-dandruff
      • 6.3.2.3. Anti-hair Fall
      • 6.3.2.4. Scalp Repair
      • 6.3.2.5. Others
    • 6.3.3. Eye Care Products
    • 6.3.4. Others
  • 6.4. Market Attractiveness By Product Type

7. Global Physician Dispensed Cosmeceuticals Market Analysis and Forecasts, By Route of Administration

  • 7.1. Introduction & Definition
  • 7.2. Key Findings / Developments
  • 7.3. Market Value Forecast By Route of Administration, 2020-2035
    • 7.3.1. Oral
    • 7.3.2. Topical
    • 7.3.3. Parenteral
    • 7.3.4. Others
  • 7.4. Market Attractiveness By Route of Administration

8. Global Physician Dispensed Cosmeceuticals Market Analysis and Forecasts, By Gender

  • 8.1. Introduction & Definition
  • 8.2. Key Findings / Developments
  • 8.3. Market Value Forecast By Gender, 2020-2035
    • 8.3.1. Male
    • 8.3.2. Female
  • 8.4. Market Attractiveness By Gender

9. Global Physician Dispensed Cosmeceuticals Market Analysis and Forecasts, By Formulation

  • 9.1. Introduction & Definition
  • 9.2. Key Findings / Developments
  • 9.3. Market Value Forecast By Formulation, 2020-2035
    • 9.3.1. Tablet
    • 9.3.2. Capsule
    • 9.3.3. Lotion
    • 9.3.4. Injectable
    • 9.3.5. Others
  • 9.4. Market Attractiveness By Formulation

10. Global Physician Dispensed Cosmeceuticals Market Analysis and Forecasts, By Distribution Channel

  • 10.1. Introduction & Definition
  • 10.2. Key Findings / Developments
  • 10.3. Market Value Forecast By Distribution Channel, 2020-2035
    • 10.3.1. Dermatology Clinics
    • 10.3.2. Medical Spas
    • 10.3.3. Hospitals with Dermatology Departments
    • 10.3.4. Wellness Centers
    • 10.3.5. Retail Pharmacies
    • 10.3.6. Online Platforms
  • 10.4. Market Attractiveness By Distribution Channel

11. Global Physician Dispensed Cosmeceuticals Market Analysis and Forecasts, By Region

  • 11.1. Key Findings
  • 11.2. Market Value Forecast By Region
    • 11.2.1. North America
    • 11.2.2. Europe
    • 11.2.3. Asia Pacific
    • 11.2.4. Latin America
    • 11.2.5. Middle East & Africa
  • 11.3. Market Attractiveness By Region

12. North America Physician Dispensed Cosmeceuticals Market Analysis and Forecast

  • 12.1. Introduction
    • 12.1.1. Key Findings
  • 12.2. Market Value Forecast By Product Type, 2020-2035
    • 12.2.1. Skincare Products
      • 12.2.1.1. Anti-aging Products
      • 12.2.1.2. Acne treatment Products
      • 12.2.1.3. Skin Whitening and Hyperpigmentation
      • 12.2.1.4. Dermal fillers
      • 12.2.1.5. Others
    • 12.2.2. Hair Care Products
      • 12.2.2.1. Hair Repair
      • 12.2.2.2. Anti-dandruff
      • 12.2.2.3. Anti-hair Fall
      • 12.2.2.4. Scalp Repair
      • 12.2.2.5. Others
    • 12.2.3. Eye Care Products
    • 12.2.4. Others
  • 12.3. Market Value Forecast By Route of Administration, 2020-2035
    • 12.3.1. Oral
    • 12.3.2. Topical
    • 12.3.3. Parenteral
    • 12.3.4. Others
  • 12.4. Market Value Forecast By Gender, 2020-2035
    • 12.4.1. Male
    • 12.4.2. Female
  • 12.5. Market Value Forecast By Formulation, 2020-2035
    • 12.5.1. Tablet
    • 12.5.2. Capsule
    • 12.5.3. Lotion
    • 12.5.4. Injectable
    • 12.5.5. Others
  • 12.6. Market Value Forecast By Distribution Channel, 2020-2035
    • 12.6.1. Dermatology Clinics
    • 12.6.2. Medical Spas
    • 12.6.3. Hospitals with Dermatology Departments
    • 12.6.4. Wellness Centers
    • 12.6.5. Retail Pharmacies
    • 12.6.6. Online Platforms
  • 12.7. Market Value Forecast By Country, 2020-2035
    • 12.7.1. U.S.
    • 12.7.2. Canada
  • 12.8. Market Attractiveness Analysis
    • 12.8.1. By Product Type
    • 12.8.2. By Route of Administration
    • 12.8.3. By Gender
    • 12.8.4. By Formulation
    • 12.8.5. By Distribution Channel
    • 12.8.6. By Country

13. Europe Physician Dispensed Cosmeceuticals Market Analysis and Forecast

  • 13.1. Introduction
    • 13.1.1. Key Findings
  • 13.2. Market Value Forecast By Product Type, 2020-2035
    • 13.2.1. Skincare Products
      • 13.2.1.1. Anti-aging Products
      • 13.2.1.2. Acne treatment Products
      • 13.2.1.3. Skin Whitening and Hyperpigmentation
      • 13.2.1.4. Botulinum Toxin
      • 13.2.1.5. Dermal fillers
      • 13.2.1.6. Others
    • 13.2.2. Hair Care Products
      • 13.2.2.1. Hair Repair
      • 13.2.2.2. Anti-dandruff
      • 13.2.2.3. Anti-hair Fall
      • 13.2.2.4. Scalp Repair
      • 13.2.2.5. Others
    • 13.2.3. Eye Care Products
    • 13.2.4. Others
  • 13.3. Market Value Forecast By Route of Administration, 2020-2035
    • 13.3.1. Oral
    • 13.3.2. Topical
    • 13.3.3. Parenteral
    • 13.3.4. Others
  • 13.4. Market Value Forecast By Gender, 2020-2035
    • 13.4.1. Male
    • 13.4.2. Female
  • 13.5. Market Value Forecast By Formulation, 2020-2035
    • 13.5.1. Tablet
    • 13.5.2. Capsule
    • 13.5.3. Lotion
    • 13.5.4. Injectable
    • 13.5.5. Others
  • 13.6. Market Value Forecast By Distribution Channel, 2020-2035
    • 13.6.1. Dermatology Clinics
    • 13.6.2. Medical Spas
    • 13.6.3. Hospitals with Dermatology Departments
    • 13.6.4. Wellness Centers
    • 13.6.5. Retail Pharmacies
    • 13.6.6. Online Platforms
  • 13.7. Market Value Forecast By Country/Sub-region, 2020-2035
    • 13.7.1. Germany
    • 13.7.2. U.K.
    • 13.7.3. France
    • 13.7.4. Italy
    • 13.7.5. Spain
    • 13.7.6. Rest of Europe
  • 13.8. Market Attractiveness Analysis
    • 13.8.1. By Product Type
    • 13.8.2. By Route of Administration
    • 13.8.3. By Gender
    • 13.8.4. By Formulation
    • 13.8.5. By Distribution Channel
    • 13.8.6. By Country/Sub-region

14. Asia Pacific Physician Dispensed Cosmeceuticals Market Analysis and Forecast

  • 14.1. Introduction
    • 14.1.1. Key Findings
  • 14.2. Market Value Forecast By Product Type, 2020-2035
    • 14.2.1. Skincare Products
      • 14.2.1.1. Anti-aging Products
      • 14.2.1.2. Acne treatment Products
      • 14.2.1.3. Skin Whitening and Hyperpigmentation
      • 14.2.1.4. Botulinum Toxin
      • 14.2.1.5. Dermal fillers
      • 14.2.1.6. Others
    • 14.2.2. Hair Care Products
      • 14.2.2.1. Hair Repair
      • 14.2.2.2. Anti-dandruff
      • 14.2.2.3. Anti-hair Fall
      • 14.2.2.4. Scalp Repair
      • 14.2.2.5. Others
    • 14.2.3. Eye Care Products
    • 14.2.4. Others
  • 14.3. Market Value Forecast By Route of Administration, 2020-2035
    • 14.3.1. Oral
    • 14.3.2. Topical
    • 14.3.3. Parenteral
    • 14.3.4. Others
  • 14.4. Market Value Forecast By Gender, 2020-2035
    • 14.4.1. Male
    • 14.4.2. Female
  • 14.5. Market Value Forecast By Formulation, 2020-2035
    • 14.5.1. Tablet
    • 14.5.2. Capsule
    • 14.5.3. Lotion
    • 14.5.4. Injectable
    • 14.5.5. Others
  • 14.6. Market Value Forecast By Distribution Channel, 2020-2035
    • 14.6.1. Dermatology Clinics
    • 14.6.2. Medical Spas
    • 14.6.3. Hospitals with Dermatology Departments
    • 14.6.4. Wellness Centers
    • 14.6.5. Retail Pharmacies
    • 14.6.6. Online Platforms
  • 14.7. Market Value Forecast By Country/Sub-region, 2020-2035
    • 14.7.1. China
    • 14.7.2. India
    • 14.7.3. Japan
    • 14.7.4. Australia & New Zealand
    • 14.7.5. Rest of Asia Pacific
  • 14.8. Market Attractiveness Analysis
    • 14.8.1. By Product Type
    • 14.8.2. By Route of Administration
    • 14.8.3. By Gender
    • 14.8.4. By Formulation
    • 14.8.5. By Distribution Channel
    • 14.8.6. By Country/Sub-region

15. Latin America Physician Dispensed Cosmeceuticals Market Analysis and Forecast

  • 15.1. Introduction
    • 15.1.1. Key Findings
  • 15.2. Market Value Forecast By Product Type, 2020-2035
    • 15.2.1. Skincare Products
      • 15.2.1.1. Anti-aging Products
      • 15.2.1.2. Acne treatment Products
      • 15.2.1.3. Skin Whitening and Hyperpigmentation
      • 15.2.1.4. Botulinum Toxin
      • 15.2.1.5. Dermal fillers
      • 15.2.1.6. Others
    • 15.2.2. Hair Care Products
      • 15.2.2.1. Hair Repair
      • 15.2.2.2. Anti-dandruff
      • 15.2.2.3. Anti-hair Fall
      • 15.2.2.4. Scalp Repair
      • 15.2.2.5. Others
    • 15.2.3. Eye Care Products
    • 15.2.4. Others
  • 15.3. Market Value Forecast By Route of Administration, 2020-2035
    • 15.3.1. Oral
    • 15.3.2. Topical
    • 15.3.3. Parenteral
    • 15.3.4. Others
  • 15.4. Market Value Forecast By Gender, 2020-2035
    • 15.4.1. Male
    • 15.4.2. Female
  • 15.5. Market Value Forecast By Formulation, 2020-2035
    • 15.5.1. Tablet
    • 15.5.2. Capsule
    • 15.5.3. Lotion
    • 15.5.4. Injectable
    • 15.5.5. Others
  • 15.6. Market Value Forecast By Distribution Channel, 2020-2035
    • 15.6.1. Dermatology Clinics
    • 15.6.2. Medical Spas
    • 15.6.3. Hospitals with Dermatology Departments
    • 15.6.4. Wellness Centers
    • 15.6.5. Retail Pharmacies
    • 15.6.6. Online Platforms
  • 15.7. Market Value Forecast By Country/Sub-region, 2020-2035
    • 15.7.1. Brazil
    • 15.7.2. Mexico
    • 15.7.3. Rest of Latin America
  • 15.8. Market Attractiveness Analysis
    • 15.8.1. By Product Type
    • 15.8.2. By Route of Administration
    • 15.8.3. By Gender
    • 15.8.4. By Formulation
    • 15.8.5. By Distribution Channel
    • 15.8.6. By Country/Sub-region

16. Middle East & Africa Physician Dispensed Cosmeceuticals Market Analysis and Forecast

  • 16.1. Introduction
    • 16.1.1. Key Findings
  • 16.2. Market Value Forecast By Product Type, 2020-2035
    • 16.2.1. Skincare Products
      • 16.2.1.1. Anti-aging Products
      • 16.2.1.2. Acne treatment Products
      • 16.2.1.3. Skin Whitening and Hyperpigmentation
      • 16.2.1.4. Botulinum Toxin
      • 16.2.1.5. Dermal fillers
      • 16.2.1.6. Others
    • 16.2.2. Hair Care Products
      • 16.2.2.1. Hair Repair
      • 16.2.2.2. Anti-dandruff
      • 16.2.2.3. Anti-hair Fall
      • 16.2.2.4. Scalp Repair
      • 16.2.2.5. Others
    • 16.2.3. Eye Care Products
    • 16.2.4. Others
  • 16.3. Market Value Forecast By Route of Administration, 2020-2035
    • 16.3.1. Oral
    • 16.3.2. Topical
    • 16.3.3. Parenteral
    • 16.3.4. Others
  • 16.4. Market Value Forecast By Gender, 2020-2035
    • 16.4.1. Male
    • 16.4.2. Female
  • 16.5. Market Value Forecast By Formulation, 2020-2035
    • 16.5.1. Tablet
    • 16.5.2. Capsule
    • 16.5.3. Lotion
    • 16.5.4. Injectable
    • 16.5.5. Others
  • 16.6. Market Value Forecast By Distribution Channel, 2020-2035
    • 16.6.1. Dermatology Clinics
    • 16.6.2. Medical Spas
    • 16.6.3. Hospitals with Dermatology Departments
    • 16.6.4. Wellness Centers
    • 16.6.5. Retail Pharmacies
    • 16.6.6. Online Platforms
  • 16.7. Market Value Forecast By Country/Sub-region, 2020-2035
    • 16.7.1. GCC Countries
    • 16.7.2. South Africa
    • 16.7.3. Rest of Middle East & Africa
  • 16.8. Market Attractiveness Analysis
    • 16.8.1. By Product Type
    • 16.8.2. By Route of Administration
    • 16.8.3. By Gender
    • 16.8.4. By Formulation
    • 16.8.5. By Distribution Channel
    • 16.8.6. By Country/Sub-region

17. Competition Landscape

  • 17.1. Market Player - Competition Matrix (By Tier and Size of companies)
  • 17.2. Market Share Analysis By Company (2024)
  • 17.3. Company Profiles
    • 17.3.1. AbbVie Inc. (Allergan)
      • 17.3.1.1. Company Overview
      • 17.3.1.2. Financial Overview
      • 17.3.1.3. Product Portfolio
      • 17.3.1.4. Business Strategies
      • 17.3.1.5. Recent Developments
    • 17.3.2. L'Oreal S.A. (Skinbetter Science)
      • 17.3.2.1. Company Overview
      • 17.3.2.2. Financial Overview
      • 17.3.2.3. Product Portfolio
      • 17.3.2.4. Business Strategies
      • 17.3.2.5. Recent Developments
    • 17.3.3. Jan Marini Skin Research, Inc.
      • 17.3.3.1. Company Overview
      • 17.3.3.2. Financial Overview
      • 17.3.3.3. Product Portfolio
      • 17.3.3.4. Business Strategies
      • 17.3.3.5. Recent Developments
    • 17.3.4. Athena Cosmetics, Inc.
      • 17.3.4.1. Company Overview
      • 17.3.4.2. Financial Overview
      • 17.3.4.3. Product Portfolio
      • 17.3.4.4. Business Strategies
      • 17.3.4.5. Recent Developments
    • 17.3.5. ZO Skin Health Inc.
      • 17.3.5.1. Company Overview
      • 17.3.5.2. Financial Overview
      • 17.3.5.3. Product Portfolio
      • 17.3.5.4. Business Strategies
      • 17.3.5.5. Recent Developments
    • 17.3.6. Galderma Laboratories, L.P.
      • 17.3.6.1. Company Overview
      • 17.3.6.2. Financial Overview
      • 17.3.6.3. Product Portfolio
      • 17.3.6.4. Business Strategies
      • 17.3.6.5. Recent Developments
    • 17.3.7. Procter & Gamble Co.
      • 17.3.7.1. Company Overview
      • 17.3.7.2. Financial Overview
      • 17.3.7.3. Product Portfolio
      • 17.3.7.4. Business Strategies
      • 17.3.7.5. Recent Developments
    • 17.3.8. The Estée Lauder Companies, Inc.
      • 17.3.8.1. Company Overview
      • 17.3.8.2. Financial Overview
      • 17.3.8.3. Product Portfolio
      • 17.3.8.4. Business Strategies
      • 17.3.8.5. Recent Developments
    • 17.3.9. Merz Pharma
      • 17.3.9.1. Company Overview
      • 17.3.9.2. Financial Overview
      • 17.3.9.3. Product Portfolio
      • 17.3.9.4. Business Strategies
      • 17.3.9.5. Recent Developments
    • 17.3.10. Obagi Cosmeceuticals LLC
      • 17.3.10.1. Company Overview
      • 17.3.10.2. Financial Overview
      • 17.3.10.3. Product Portfolio
      • 17.3.10.4. Business Strategies
      • 17.3.10.5. Recent Developments
    • 17.3.11. iS CLINICAL
      • 17.3.11.1. Company Overview
      • 17.3.11.2. Financial Overview
      • 17.3.11.3. Product Portfolio
      • 17.3.11.4. Business Strategies
      • 17.3.11.5. Recent Developments
    • 17.3.12. Velius, LLC
      • 17.3.12.1. Company Overview
      • 17.3.12.2. Financial Overview
      • 17.3.12.3. Product Portfolio
      • 17.3.12.4. Business Strategies
      • 17.3.12.5. Recent Developments
    • 17.3.13. Sonoma Pharmaceuticals, Inc.
      • 17.3.13.1. Company Overview
      • 17.3.13.2. Financial Overview
      • 17.3.13.3. Product Portfolio
      • 17.3.13.4. Business Strategies
      • 17.3.13.5. Recent Developments
    • 17.3.14. Sientra, Inc.
      • 17.3.14.1. Company Overview
      • 17.3.14.2. Financial Overview
      • 17.3.14.3. Product Portfolio
      • 17.3.14.4. Business Strategies
      • 17.3.14.5. Recent Developments
    • 17.3.15. Dynamic Techno Medicals
      • 17.3.15.1. Company Overview
      • 17.3.15.2. Financial Overview
      • 17.3.15.3. Product Portfolio
      • 17.3.15.4. Business Strategies
      • 17.3.15.5. Recent Developments
    • 17.3.16. Bausch Health Companies Inc.
      • 17.3.16.1. Company Overview
      • 17.3.16.2. Financial Overview
      • 17.3.16.3. Product Portfolio
      • 17.3.16.4. Business Strategies
      • 17.3.16.5. Recent Developments

List of Tables

  • Table 01: Global Physician Dispensed Cosmeceuticals Market Value (US$ Bn) Forecast, By Product Type, 2020-2035
  • Table 02: Global Physician Dispensed Cosmeceuticals Market Value (US$ Bn) Forecast, By Skincare Products, 2020-2035
  • Table 03: Global Physician Dispensed Cosmeceuticals Market Value (US$ Bn) Forecast, By Hair Care Products, 2020-2035
  • Table 04: Global Physician Dispensed Cosmeceuticals Market Value (US$ Bn) Forecast, By Route of Administration, 2020-2035
  • Table 05: Global Physician Dispensed Cosmeceuticals Market Value (US$ Bn) Forecast, By Gender, 2020-2035
  • Table 06: Global Physician Dispensed Cosmeceuticals Market Value (US$ Bn) Forecast, By Formulation, 2020-2035
  • Table 07: Global Physician Dispensed Cosmeceuticals Market Value (US$ Bn) Forecast, By Distribution Channel, 2020-2035
  • Table 08: Global Physician Dispensed Cosmeceuticals Market Value (US$ Bn) Forecast, By Region, 2020-2035
  • Table 09: North America - Physician Dispensed Cosmeceuticals Market Value (US$ Bn) Forecast, by Country, 2020-2035
  • Table 10: North America - Physician Dispensed Cosmeceuticals Market Value (US$ Bn) Forecast, by Product Type, 2020-2035
  • Table 11: North America - Physician Dispensed Cosmeceuticals Market Value (US$ Bn) Forecast, by Skincare Products, 2020-2035
  • Table 12: North America - Physician Dispensed Cosmeceuticals Market Value (US$ Bn) Forecast, by Hair Care Products, 2020-2035
  • Table 13: North America - Physician Dispensed Cosmeceuticals Market Value (US$ Bn) Forecast, By Route of Administration, 2020-2035
  • Table 14: North America - Physician Dispensed Cosmeceuticals Market Value (US$ Bn) Forecast, By Gender, 2020-2035
  • Table 15: North America - Physician Dispensed Cosmeceuticals Market Value (US$ Bn) Forecast, By Formulation, 2020-2035
  • Table 16: North America - Physician Dispensed Cosmeceuticals Market Value (US$ Bn) Forecast, By Distribution Channel, 2020-2035
  • Table 17: Europe - Physician Dispensed Cosmeceuticals Market Value (US$ Bn) Forecast, by Country/Sub-region, 2020-2035
  • Table 18: Europe - Physician Dispensed Cosmeceuticals Market Value (US$ Bn) Forecast, by Product Type, 2020-2035
  • Table 19: Europe - Physician Dispensed Cosmeceuticals Market Value (US$ Bn) Forecast, by Skincare Products, 2020-2035
  • Table 20: Europe - Physician Dispensed Cosmeceuticals Market Value (US$ Bn) Forecast, by Hair Care Products, 2020-2035
  • Table 21: Europe - Physician Dispensed Cosmeceuticals Market Value (US$ Bn) Forecast, By Route of Administration, 2020-2035
  • Table 22: Europe - Physician Dispensed Cosmeceuticals Market Value (US$ Bn) Forecast, By Gender, 2020-2035
  • Table 23: Europe - Physician Dispensed Cosmeceuticals Market Value (US$ Bn) Forecast, By Formulation, 2020-2035
  • Table 24: Europe - Physician Dispensed Cosmeceuticals Market Value (US$ Bn) Forecast, By Distribution Channel, 2020-2035
  • Table 25: Asia Pacific - Physician Dispensed Cosmeceuticals Market Value (US$ Bn) Forecast, by Country/Sub-region, 2020-2035
  • Table 26: Asia Pacific - Physician Dispensed Cosmeceuticals Market Value (US$ Bn) Forecast, by Product Type, 2020-2035
  • Table 27: Asia Pacific - Physician Dispensed Cosmeceuticals Market Value (US$ Bn) Forecast, by Skincare Products, 2020-2035
  • Table 28: Asia Pacific - Physician Dispensed Cosmeceuticals Market Value (US$ Bn) Forecast, by Hair Care Products, 2020-2035
  • Table 29: Asia Pacific - Physician Dispensed Cosmeceuticals Market Value (US$ Bn) Forecast, By Route of Administration, 2020-2035
  • Table 30: Asia Pacific - Physician Dispensed Cosmeceuticals Market Value (US$ Bn) Forecast, By Gender, 2020-2035
  • Table 31: Asia Pacific - Physician Dispensed Cosmeceuticals Market Value (US$ Bn) Forecast, By Formulation, 2020-2035
  • Table 32: Asia Pacific - Physician Dispensed Cosmeceuticals Market Value (US$ Bn) Forecast, By Distribution Channel, 2020-2035
  • Table 33: Latin America - Physician Dispensed Cosmeceuticals Market Value (US$ Bn) Forecast, by Country/Sub-region, 2020-2035
  • Table 34: Latin America - Physician Dispensed Cosmeceuticals Market Value (US$ Bn) Forecast, by Product Type, 2020-2035
  • Table 35: Latin America - Physician Dispensed Cosmeceuticals Market Value (US$ Bn) Forecast, by Skincare Products, 2020-2035
  • Table 36: Latin America - Physician Dispensed Cosmeceuticals Market Value (US$ Bn) Forecast, by Hair Care Products, 2020-2035
  • Table 37: Latin America - Physician Dispensed Cosmeceuticals Market Value (US$ Bn) Forecast, By Route of Administration, 2020-2035
  • Table 38: Latin America - Physician Dispensed Cosmeceuticals Market Value (US$ Bn) Forecast, By Gender, 2020-2035
  • Table 39: Latin America - Physician Dispensed Cosmeceuticals Market Value (US$ Bn) Forecast, By Formulation, 2020-2035
  • Table 40: Latin America - Physician Dispensed Cosmeceuticals Market Value (US$ Bn) Forecast, By Distribution Channel, 2020-2035
  • Table 41: Middle East and Africa - Physician Dispensed Cosmeceuticals Market Value (US$ Bn) Forecast, by Country/Sub-region, 2020-2035
  • Table 42: Middle East and Africa - Physician Dispensed Cosmeceuticals Market Value (US$ Bn) Forecast, by Product Type, 2020-2035
  • Table 43: Middle East and Africa - Physician Dispensed Cosmeceuticals Market Value (US$ Bn) Forecast, by Skincare Products, 2020-2035
  • Table 44: Middle East and Africa - Physician Dispensed Cosmeceuticals Market Value (US$ Bn) Forecast, by Hair Care Products, 2020-2035
  • Table 45: Middle East and Africa - Physician Dispensed Cosmeceuticals Market Value (US$ Bn) Forecast, By Route of Administration, 2020-2035
  • Table 46: Middle East and Africa - Physician Dispensed Cosmeceuticals Market Value (US$ Bn) Forecast, By Gender, 2020-2035
  • Table 47: Middle East and Africa - Physician Dispensed Cosmeceuticals Market Value (US$ Bn) Forecast, By Formulation, 2020-2035
  • Table 48: Middle East and Africa - Physician Dispensed Cosmeceuticals Market Value (US$ Bn) Forecast, By Distribution Channel, 2020-2035

List of Figures

  • Figure 01: Global Physician Dispensed Cosmeceuticals Market Value Share Analysis, By Product Type, 2024 and 2035
  • Figure 02: Global Physician Dispensed Cosmeceuticals Market Attractiveness Analysis, By Product Type, 2025-2035
  • Figure 03: Global Physician Dispensed Cosmeceuticals Market Revenue (US$ Bn), by Skincare Products, 2020-2035
  • Figure 04: Global Physician Dispensed Cosmeceuticals Market Revenue (US$ Bn), by Hair Care Products, 2020-2035
  • Figure 05: Global Physician Dispensed Cosmeceuticals Market Revenue (US$ Bn), by Eye Care Products, 2020-2035
  • Figure 06: Global Physician Dispensed Cosmeceuticals Market Revenue (US$ Bn), by Others, 2020-2035
  • Figure 07: Global Physician Dispensed Cosmeceuticals Market Value Share Analysis, By Route of Administration, 2024 and 2035
  • Figure 08: Global Physician Dispensed Cosmeceuticals Market Attractiveness Analysis, By Route of Administration, 2025-2035
  • Figure 09: Global Physician Dispensed Cosmeceuticals Market Revenue (US$ Bn), by Oral, 2020-2035
  • Figure 10: Global Physician Dispensed Cosmeceuticals Market Revenue (US$ Bn), by Topical, 2020-2035
  • Figure 11: Global Physician Dispensed Cosmeceuticals Market Revenue (US$ Bn), by Parenteral, 2020-2035
  • Figure 12: Global Physician Dispensed Cosmeceuticals Market Revenue (US$ Bn), by Others, 2020-2035
  • Figure 13: Global Physician Dispensed Cosmeceuticals Market Value Share Analysis, By Gender, 2024 and 2035
  • Figure 14: Global Physician Dispensed Cosmeceuticals Market Attractiveness Analysis, By Gender, 2025-2035
  • Figure 15: Global Physician Dispensed Cosmeceuticals Market Revenue (US$ Bn), by Male, 2020-2035
  • Figure 16: Global Physician Dispensed Cosmeceuticals Market Revenue (US$ Bn), by Female, 2020-2035
  • Figure 17: Global Physician Dispensed Cosmeceuticals Market Value Share Analysis, By Formulation, 2024 and 2035
  • Figure 18: Global Physician Dispensed Cosmeceuticals Market Attractiveness Analysis, By Formulation, 2025-2035
  • Figure 19: Global Physician Dispensed Cosmeceuticals Market Revenue (US$ Bn), by Tablet, 2020-2035
  • Figure 20: Global Physician Dispensed Cosmeceuticals Market Revenue (US$ Bn), by Capsule, 2020-2035
  • Figure 21: Global Physician Dispensed Cosmeceuticals Market Revenue (US$ Bn), by Lotion, 2020-2035
  • Figure 22: Global Physician Dispensed Cosmeceuticals Market Revenue (US$ Bn), by Injectable, 2020-2035
  • Figure 23: Global Physician Dispensed Cosmeceuticals Market Revenue (US$ Bn), by Others, 2020-2035
  • Figure 24: Global Physician Dispensed Cosmeceuticals Market Value Share Analysis, By Distribution Channel, 2024 and 2035
  • Figure 25: Global Physician Dispensed Cosmeceuticals Market Attractiveness Analysis, By Distribution Channel, 2025-2035
  • Figure 26: Global Physician Dispensed Cosmeceuticals Market Revenue (US$ Bn), by Dermatology Clinics, 2020-2035
  • Figure 27: Global Physician Dispensed Cosmeceuticals Market Revenue (US$ Bn), by Medical Spas, 2020-2035
  • Figure 28: Global Physician Dispensed Cosmeceuticals Market Revenue (US$ Bn), by Hospitals with Dermatology Departments, 2020-2035
  • Figure 29: Global Physician Dispensed Cosmeceuticals Market Revenue (US$ Bn), by Wellness Centers, 2020-2035
  • Figure 30: Global Physician Dispensed Cosmeceuticals Market Revenue (US$ Bn), by Retail Pharmacies, 2020-2035
  • Figure 31: Global Physician Dispensed Cosmeceuticals Market Revenue (US$ Bn), by Online Platforms, 2020-2035
  • Figure 32: Global Physician Dispensed Cosmeceuticals Market Value Share Analysis, By Region, 2024 and 2035
  • Figure 33: Global Physician Dispensed Cosmeceuticals Market Attractiveness Analysis, By Region, 2025-2035
  • Figure 34: North America - Physician Dispensed Cosmeceuticals Market Value (US$ Bn) Forecast, 2020-2035
  • Figure 35: North America - Physician Dispensed Cosmeceuticals Market Value Share Analysis, by Country, 2024 and 2035
  • Figure 36: North America - Physician Dispensed Cosmeceuticals Market Attractiveness Analysis, by Country, 2025-2035
  • Figure 37: North America - Physician Dispensed Cosmeceuticals Market Value Share Analysis, By Product Type, 2024 and 2035
  • Figure 38: North America - Physician Dispensed Cosmeceuticals Market Attractiveness Analysis, By Product Type, 2025-2035
  • Figure 39: North America - Physician Dispensed Cosmeceuticals Market Value Share Analysis, By Route of Administration, 2024 and 2035
  • Figure 40: North America - Physician Dispensed Cosmeceuticals Market Attractiveness Analysis, By Route of Administration, 2025-2035
  • Figure 41: North America - Physician Dispensed Cosmeceuticals Market Value Share Analysis, By Gender, 2024 and 2035
  • Figure 42: North America - Physician Dispensed Cosmeceuticals Market Attractiveness Analysis, By Gender, 2025-2035
  • Figure 43: North America - Physician Dispensed Cosmeceuticals Market Value Share Analysis, By Formulation, 2024 and 2035
  • Figure 44: North America - Physician Dispensed Cosmeceuticals Market Attractiveness Analysis, By Formulation, 2025-2035
  • Figure 45: North America - Physician Dispensed Cosmeceuticals Market Value Share Analysis, By Distribution Channel, 2024 and 2035
  • Figure 46: North America - Physician Dispensed Cosmeceuticals Market Attractiveness Analysis, By Distribution Channel, 2025-2035
  • Figure 47: Europe - Physician Dispensed Cosmeceuticals Market Value (US$ Bn) Forecast, 2020-2035
  • Figure 48: Europe - Physician Dispensed Cosmeceuticals Market Value Share Analysis, by Country/Sub-region, 2024 and 2035
  • Figure 49: Europe - Physician Dispensed Cosmeceuticals Market Attractiveness Analysis, by Country/Sub-region, 2025-2035
  • Figure 50: Europe - Physician Dispensed Cosmeceuticals Market Value Share Analysis, By Product Type, 2024 and 2035
  • Figure 51: Europe - Physician Dispensed Cosmeceuticals Market Attractiveness Analysis, By Product Type, 2025-2035
  • Figure 52: Europe - Physician Dispensed Cosmeceuticals Market Value Share Analysis, By Route of Administration, 2024 and 2035
  • Figure 53: Europe - Physician Dispensed Cosmeceuticals Market Attractiveness Analysis, By Route of Administration, 2025-2035
  • Figure 54: Europe - Physician Dispensed Cosmeceuticals Market Value Share Analysis, By Gender, 2024 and 2035
  • Figure 55: Europe - Physician Dispensed Cosmeceuticals Market Attractiveness Analysis, By Gender, 2025-2035
  • Figure 56: Europe - Physician Dispensed Cosmeceuticals Market Value Share Analysis, By Formulation, 2024 and 2035
  • Figure 57: Europe - Physician Dispensed Cosmeceuticals Market Attractiveness Analysis, By Formulation, 2025-2035
  • Figure 58: Europe - Physician Dispensed Cosmeceuticals Market Value Share Analysis, By Distribution Channel, 2024 and 2035
  • Figure 59: Europe - Physician Dispensed Cosmeceuticals Market Attractiveness Analysis, By Distribution Channel, 2025-2035
  • Figure 60: Asia Pacific - Physician Dispensed Cosmeceuticals Market Value (US$ Bn) Forecast, 2020-2035
  • Figure 61: Asia Pacific - Physician Dispensed Cosmeceuticals Market Value Share Analysis, by Country/Sub-region, 2024 and 2035
  • Figure 62: Asia Pacific - Physician Dispensed Cosmeceuticals Market Attractiveness Analysis, by Country/Sub-region, 2025-2035
  • Figure 63: Asia Pacific - Physician Dispensed Cosmeceuticals Market Value Share Analysis, By Product Type, 2024 and 2035
  • Figure 64: Asia Pacific - Physician Dispensed Cosmeceuticals Market Attractiveness Analysis, By Product Type, 2025-2035
  • Figure 65: Asia Pacific - Physician Dispensed Cosmeceuticals Market Value Share Analysis, By Route of Administration, 2024 and 2035
  • Figure 66: Asia Pacific - Physician Dispensed Cosmeceuticals Market Attractiveness Analysis, By Route of Administration, 2025-2035
  • Figure 67: Asia Pacific - Physician Dispensed Cosmeceuticals Market Value Share Analysis, By Gender, 2024 and 2035
  • Figure 68: Asia Pacific - Physician Dispensed Cosmeceuticals Market Attractiveness Analysis, By Gender, 2025-2035
  • Figure 69: Asia Pacific - Physician Dispensed Cosmeceuticals Market Value Share Analysis, By Formulation, 2024 and 2035
  • Figure 70: Asia Pacific - Physician Dispensed Cosmeceuticals Market Attractiveness Analysis, By Formulation, 2025-2035
  • Figure 71: Asia Pacific - Physician Dispensed Cosmeceuticals Market Value Share Analysis, By Distribution Channel, 2024 and 2035
  • Figure 72: Asia Pacific - Physician Dispensed Cosmeceuticals Market Attractiveness Analysis, By Distribution Channel, 2025-2035
  • Figure 73: Latin America - Physician Dispensed Cosmeceuticals Market Value (US$ Bn) Forecast, 2020-2035
  • Figure 74: Latin America - Physician Dispensed Cosmeceuticals Market Value Share Analysis, by Country/Sub-region, 2024 and 2035
  • Figure 75: Latin America - Physician Dispensed Cosmeceuticals Market Attractiveness Analysis, by Country/Sub-region, 2025-2035
  • Figure 76: Latin America - Physician Dispensed Cosmeceuticals Market Value Share Analysis, By Product Type, 2024 and 2035
  • Figure 77: Latin America - Physician Dispensed Cosmeceuticals Market Attractiveness Analysis, By Product Type, 2025-2035
  • Figure 78: Latin America - Physician Dispensed Cosmeceuticals Market Value Share Analysis, By Route of Administration, 2024 and 2035
  • Figure 79: Latin America - Physician Dispensed Cosmeceuticals Market Attractiveness Analysis, By Route of Administration, 2025-2035
  • Figure 80: Latin America - Physician Dispensed Cosmeceuticals Market Value Share Analysis, By Gender, 2024 and 2035
  • Figure 81: Latin America - Physician Dispensed Cosmeceuticals Market Attractiveness Analysis, By Gender, 2025-2035
  • Figure 82: Latin America - Physician Dispensed Cosmeceuticals Market Value Share Analysis, By Formulation, 2024 and 2035
  • Figure 83: Latin America - Physician Dispensed Cosmeceuticals Market Attractiveness Analysis, By Formulation, 2025-2035
  • Figure 84: Latin America - Physician Dispensed Cosmeceuticals Market Value Share Analysis, By Distribution Channel, 2024 and 2035
  • Figure 85: Latin America - Physician Dispensed Cosmeceuticals Market Attractiveness Analysis, By Distribution Channel, 2025-2035
  • Figure 86: Middle East and Africa - Physician Dispensed Cosmeceuticals Market Value (US$ Bn) Forecast, 2020-2035
  • Figure 87: Middle East and Africa - Physician Dispensed Cosmeceuticals Market Value Share Analysis, by Country/Sub-region, 2024 and 2035
  • Figure 88: Middle East and Africa - Physician Dispensed Cosmeceuticals Market Attractiveness Analysis, by Country/Sub-region, 2025-2035
  • Figure 89: Middle East and Africa - Physician Dispensed Cosmeceuticals Market Value Share Analysis, By Product Type, 2024 and 2035
  • Figure 90: Middle East and Africa - Physician Dispensed Cosmeceuticals Market Attractiveness Analysis, By Product Type, 2025-2035
  • Figure 91: Middle East and Africa - Physician Dispensed Cosmeceuticals Market Value Share Analysis, By Route of Administration, 2024 and 2035
  • Figure 92: Middle East and Africa - Physician Dispensed Cosmeceuticals Market Attractiveness Analysis, By Route of Administration, 2025-2035
  • Figure 93: Middle East and Africa - Physician Dispensed Cosmeceuticals Market Value Share Analysis, By Gender, 2024 and 2035
  • Figure 94: Middle East and Africa - Physician Dispensed Cosmeceuticals Market Attractiveness Analysis, By Gender, 2025-2035
  • Figure 95: Middle East and Africa - Physician Dispensed Cosmeceuticals Market Value Share Analysis, By Formulation, 2024 and 2035
  • Figure 96: Middle East and Africa - Physician Dispensed Cosmeceuticals Market Attractiveness Analysis, By Formulation, 2025-2035
  • Figure 97: Middle East and Africa - Physician Dispensed Cosmeceuticals Market Value Share Analysis, By Distribution Channel, 2024 and 2035
  • Figure 98: Middle East and Africa - Physician Dispensed Cosmeceuticals Market Attractiveness Analysis, By Distribution Channel, 2025-2035